{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:40:26Z","timestamp":1784133626499,"version":"3.55.0"},"reference-count":56,"publisher":"Akademiai Kiado Zrt.","issue":"3","content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["AMicr"],"published-print":{"date-parts":[[2025,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Escherichia coli<\/jats:italic> is a highly adaptable Gram-negative bacterium, commonly part of the gut microbiota in humans and animals, yet capable of causing severe extraintestinal infections. Among its lineages, Sequence Type 131 (ST131) has emerged as a globally disseminated, multidrug-resistant, high-risk clone with remarkable capacity for systemic infections. This study provides a comprehensive molecular epidemiological characterization of 160 clinical <jats:italic>E. coli<\/jats:italic> isolates, collected between 15.09.2021 and 28.02.2022, assessing antimicrobial resistance profiles, virulence gene carriage, phylogenetic group distribution, prevalence of ST131 and H30Rx subclone, and biofilm-forming capacity. Isolates were identified by conventional and automated methods, with molecular analyses performed via in-house PCR assays. Our results reveal a striking 69.38% prevalence of ST131, with 95.5% harboring virulence genes and 81.99% exhibiting biofilm formation. Notably, ST131-positive isolates demonstrated extensive resistance to multiple antimicrobial classes, including ESBL production, and were dominated by the H30Rx subclone. Specifically, 73.87% of ST131 isolates were ESBL-positive, fluoroquinolone resistance was observed in 81.37%, while aminoglycoside resistance rate remained very low. The H30Rx subclone was strongly associated with ESBL positivity and multidrug resistance. Moreover, integron carriage diversity and strong association with <jats:italic>fimA<\/jats:italic> virulence gene further highlight the adaptive versatility of this clone. Given that ST131 and its H30Rx subclone are recognized as global pandemic lineages associated with multidrug resistance and severe infections, their detection in our cohort emphasizes both the clinical relevance and the public health risk posed by these clones. Our findings underscore the urgent need for targeted surveillance and control strategies, offering novel epidemiological insights into the molecular diversity and clinical threat posed by <jats:italic>E. coli<\/jats:italic> ST131 in Turkey.<\/jats:p>","DOI":"10.1556\/030.2025.02710","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:54:21Z","timestamp":1759240461000},"page":"226-236","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":2,"title":["Investigations of Escherichia coli ST131 and H30Rx subclone from clinical samples"],"prefix":"10.1556","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0877-453X","authenticated-orcid":true,"given":"Elif","family":"Aydin","sequence":"first","affiliation":[{"name":"Disinfection Sterilization and Antisepsis Department, K\u00fctahya Health Sciences University, 43000, Kutahya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0188-9668","authenticated-orcid":true,"given":"Selahattin","family":"Celebi","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Ataturk University, 25240, Erzurum, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4578-9474","authenticated-orcid":true,"given":"Ozgur","family":"Celebi","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Ataturk University, 25240, Erzurum, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2355-0561","authenticated-orcid":true,"given":"Demet","family":"Celebi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Veterinary Medicine, Ataturk University, 25240, Erzurum, Turkey"},{"name":"Vaccine Application and Development Center, Ataturk University, 25240, Erzurum, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3506-0324","authenticated-orcid":true,"given":"Ali","family":"Taghizadehghalehjoughi","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmacology, Faculty of Medicine, Bilecik \u015eeyh Edebali University, 11230, Bilecik, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"issue":"1","key":"B1","series-title":"Infect Epidemiol Microbiol","first-page":"15","article-title":"Association between ESBLs genes and quinolone resistance in uropathogenic Escherichia coli isolated from patients with urinary tract infection","volume":"5","author":"Shivaee A","year":"2019","unstructured":"Shivaee A, Mirshekar M. Association between ESBLs genes and quinolone resistance in uropathogenic Escherichia coli isolated from patients with urinary tract infection. Infect Epidemiol Microbiol 2019; 5(1): 15\u201323."},{"issue":"11","key":"B2","series-title":"Microb Drug Resist","first-page":"1513","article-title":"The challenge of global emergence of novel colistin-resistant Escherichia coli ST131","volume":"27","author":"Taati Moghadam M","year":"2021","unstructured":"Taati Moghadam M, Mirzaei M, Fazel Tehrani Moghaddam M, Babakhani S, Yeganeh O, Asgharzadeh S, et\u00a0al. The challenge of global emergence of novel colistin-resistant Escherichia coli ST131. Microb Drug Resist 2021; 27(11): 1513\u201324."},{"issue":"6","key":"B3","series-title":"Mol Med Rep","first-page":"1","article-title":"Effect of the combination of Lactobacillus acidophilus (probiotic) with vitamin K3 and vitamin E on Escherichia coli and staphylococcus aureus: an in vitro pathogen model","volume":"27","author":"Celebi O","year":"2023","unstructured":"Celebi O, Taghizadehghalehjoughi A, Celebi D, Mesnage R, Golokhvast K S, Arsene AL, et\u00a0al. Effect of the combination of Lactobacillus acidophilus (probiotic) with vitamin K3 and vitamin E on Escherichia coli and staphylococcus aureus: an in vitro pathogen model. Mol Med Rep 2023; 27(6): 1\u201312."},{"issue":"1","key":"B4","series-title":"J Health Sci Med","first-page":"28","article-title":"Retrospective analysis of urine culture results in our clinic: determination of pathogen types and antibiotic resistance in our region","volume":"4","author":"Tekin M","year":"2021","unstructured":"Tekin M, Uzun ND, Uzun F, Sanmak E. Retrospective analysis of urine culture results in our clinic: determination of pathogen types and antibiotic resistance in our region. J Health Sci Med 2021; 4(1): 28\u201332."},{"issue":"4","key":"B5","series-title":"Clin Infect Dis","first-page":"273","article-title":"Extended-spectrum \u03b2-lactamases","volume":"41","author":"Turner PJ","year":"2005","unstructured":"Turner PJ. Extended-spectrum \u03b2-lactamases. Clin Infect Dis 2005; 41(4): 273\u20135."},{"issue":"3","key":"B6","series-title":"Kafkas \u00dcniversitesi Veteriner Fak\u00fcltesi Dergisi","article-title":"Evaluation of antimicrobial and antibiofilm efficacy of bee venom and exosome against Escherichia coli K99 strain","volume":"29","author":"Celebi D","year":"2023","unstructured":"Celebi D, Celebi O, Baser S, Tagh\u0131zadehghalehjough\u0131 A. Evaluation of antimicrobial and antibiofilm efficacy of bee venom and exosome against Escherichia coli K99 strain. Kafkas \u00dcniversitesi Veteriner Fak\u00fcltesi Dergisi 2023; 29(3)."},{"issue":"5","key":"B7","series-title":"J Antimicrob Chemother","first-page":"507","article-title":"Plasmid-determined \u03b2-lactamases identified in a group of 204 ampicillin-resistant enterobacteriaceae","volume":"12","author":"Roy C","year":"1983","unstructured":"Roy C, Foz A, Segura C, Tirado M, Foster C, Reig R. Plasmid-determined \u03b2-lactamases identified in a group of 204 ampicillin-resistant enterobacteriaceae. J Antimicrob Chemother 1983; 12(5): 507\u2013510."},{"issue":"suppl_A","key":"B8","series-title":"J\u00a0Antimicrob Chemother","first-page":"19","article-title":"Extended-spectrum plasmid-mediated \u03b2-lactamases","volume":"36","author":"Sirot D","year":"1995","unstructured":"Sirot D. Extended-spectrum plasmid-mediated \u03b2-lactamases. J\u00a0Antimicrob Chemother 1995; 36(suppl_A): 19\u201334."},{"issue":"7","key":"B9","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1128\/AAC.02252-12","article-title":"Prevalence of beta-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY antimicrobial surveillance program (2010)","volume":"57","author":"Castanheira M","year":"2013","unstructured":"Castanheira M, Farrell SE, Deshpande LM, Mendes RE, Jones RN. Prevalence of beta-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY antimicrobial surveillance program (2010). Antimicrob Agents Chemother 2013; 57(7): 3012\u201320. 10.1128\/AAC.02252-12https:\/\/doi.org\/10.1128\/AAC.02252-12"},{"issue":"14","key":"B10","series-title":"Int J Mol Sci","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.3390\/ijms21145090","article-title":"Molecular mechanisms, epidemiology, and clinical importance of beta-lactam resistance in Enterobacteriaceae","volume":"21","author":"De Angelis G","year":"2020","unstructured":"De Angelis G, Del Giacomo P, Posteraro B, Sanguinetti M, Tumbarello M. Molecular mechanisms, epidemiology, and clinical importance of beta-lactam resistance in Enterobacteriaceae. Int J Mol Sci 2020; 21(14): 5090. 10.3390\/ijms21145090https:\/\/doi.org\/10.3390\/ijms21145090"},{"key":"B11","series-title":"Adv Appl Microbiol","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/bs.aambs.2014.09.002","article-title":"Escherichia coli ST131: the quintessential example of an international multiresistant high risk clone","volume":"90","author":"Mathers AJ","year":"2015","unstructured":"Mathers AJ, Peirano G, Pitout JD. Escherichia coli ST131: the quintessential example of an international multiresistant high risk clone. Adv Appl Microbiol 2015; 90: 109\u201354. 10.1016\/bs.aambs.2014.09.002https:\/\/doi.org\/10.1016\/bs.aambs.2014.09.002"},{"issue":"3","key":"B12","series-title":"Clin Microbiol Rev","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1128\/CMR.00125-13","article-title":"Escherichia coli ST131, an intriguing clonal group","volume":"27","author":"Nicholas-Chanoine MH","year":"2014","unstructured":"Nicholas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 2014; 27(3): 543\u201374. 10.1128\/CMR.00125-13https:\/\/doi.org\/10.1128\/CMR.00125-13"},{"issue":"5","key":"B13","series-title":"FEMS Microbiol Rev","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1574-6976.2011.00268.x","article-title":"Multiresistant Gram-negative bacteria: the role of high risk clones in the dissemination of antibiotic resistance","volume":"35","author":"Woodford N","year":"2011","unstructured":"Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011; 35(5): 736\u201355. 10.1111\/j.1574-6976.2011.00268.xhttps:\/\/doi.org\/10.1111\/j.1574-6976.2011.00268.x"},{"issue":"4","key":"B14","series-title":"Mikrobiyol Bul","doi-asserted-by":"publisher","first-page":"603","DOI":"10.5578\/mb.6383","article-title":"Antibiotic resistance patterns of Escherichia coli strains isolated from urine cultures in Turkey: a meta-analysis","volume":"47","author":"Aykan SB","year":"2013","unstructured":"Aykan SB, Ciftci IH. Antibiotic resistance patterns of Escherichia coli strains isolated from urine cultures in Turkey: a meta-analysis. Mikrobiyol Bul 2013; 47(4): 603\u201318. 10.5578\/mb.6383https:\/\/doi.org\/10.5578\/mb.6383"},{"issue":"3","key":"B15","series-title":"Turk J Med Sci","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3906\/sag-1006-1893","article-title":"A pooled analysis of the resistance patterns of Escherichia coli strains isolated from urine cultures in Turkey: a comparison of the periods 1997-2001 and 2002-2007","volume":"41","author":"Ta\u015fbakan MI","year":"2011","unstructured":"Ta\u015fbakan MI, Pulluk\u00e7u H, Sipahi OR, Yamazhan T, Arda B, Ulusoy S. A pooled analysis of the resistance patterns of Escherichia coli strains isolated from urine cultures in Turkey: a comparison of the periods 1997-2001 and 2002-2007. Turk J Med Sci 2011; 41(3): 557\u201364. 10.3906\/sag-1006-1893https:\/\/doi.org\/10.3906\/sag-1006-1893"},{"issue":"4","key":"B16","series-title":"J Chemother","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1179\/joc.2009.21.4.383","article-title":"Antimicrobial resistance in gram-negative hospital isolates: results of the Turkish HITIT-2 surveillance study of 2007","volume":"21","author":"Gur D","year":"2009","unstructured":"Gur D, Hascelik G, Aydin ND, Telli M, G\u00fcltekin M, \u00d6g\u00fcn\u00e7 D, et al. Antimicrobial resistance in gram-negative hospital isolates: results of the Turkish HITIT-2 surveillance study of 2007. J Chemother 2009; 21(4): 383\u2013389. 10.1179\/joc.2009.21.4.383https:\/\/doi.org\/10.1179\/joc.2009.21.4.383"},{"issue":"1","key":"B17","series-title":"Mikrobiyol Bul","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5578\/mb.8437","article-title":"Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates","volume":"49","author":"G\u00f6rge\u00e7 S","year":"2015","unstructured":"G\u00f6rge\u00e7 S, Kuzucu \u00c7, Otlu B, Yetkin F, Ersoy Y. Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates. Mikrobiyol Bul 2015; 49(1): 15\u201325. 10.5578\/mb.8437https:\/\/doi.org\/10.5578\/mb.8437"},{"issue":"11","key":"B18","series-title":"J Antibiot","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/ja.2013.72","article-title":"Nationwide study of Escherichia coli producing extended-spectrum beta-lactamases TEM, SHV and CTX-M in Turkey","volume":"66","author":"Saral A","year":"2013","unstructured":"Saral A, Yasar E, Cizmeci Z, Ozlem Balci P, Esra Budak E. Nationwide study of Escherichia coli producing extended-spectrum beta-lactamases TEM, SHV and CTX-M in Turkey. J Antibiot 2013; 66(11): 647\u201350. 10.1038\/ja.2013.72https:\/\/doi.org\/10.1038\/ja.2013.72"},{"issue":"2","key":"B19","series-title":"Clin Microbiol Infect","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1469-0691.2009.02941.x","article-title":"Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections","volume":"16","author":"Azap \u00d6K","year":"2010","unstructured":"Azap \u00d6K, Arslan H, Serefhano\u011flu K, \u00c7olako\u011flu \u015e, Erdo\u011fan H, Timurkaynak F, et al. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect 2010; 16(2): 147\u201351. 10.1111\/j.1469-0691.2009.02941.xhttps:\/\/doi.org\/10.1111\/j.1469-0691.2009.02941.x"},{"issue":"4","key":"B20","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/cid\/ciu864","article-title":"Emerging Escherichia coli O25b\/ST131 clone predicts treatment failure in urinary tract infections","volume":"60","author":"Can F","year":"2015","unstructured":"Can F, Azap OK, Seref C, Ispir P, Arslan H, Ergonul O. Emerging Escherichia coli O25b\/ST131 clone predicts treatment failure in urinary tract infections. Clin Infect Dis 2015; 60(4): 523\u20137. 10.1093\/cid\/ciu864https:\/\/doi.org\/10.1093\/cid\/ciu864"},{"key":"B21","series-title":"J Glob Antimicrob Resist","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jgar.2015.10.006","article-title":"The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli","volume":"4","author":"Can F","year":"2016","unstructured":"Can F, Kurt-Azap \u00d6, \u0130spir P, Nurtop E, Seref C, Lo\u00e7lar \u0130, et al. The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli. J Glob Antimicrob Resist 2016; 4: 49\u201352. 10.1016\/j.jgar.2015.10.006https:\/\/doi.org\/10.1016\/j.jgar.2015.10.006"},{"issue":"8","key":"B22","series-title":"Microb Drug Resist","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1089\/mdr.2017.0021","article-title":"A first insight into Escherichia coli ST131 high-risk clone among extended-spectrum beta-lactamase-producing urine isolates in Istanbul with the use of matrix-assisted laser desorption\/ionization time-of-flight mass-spectrometry and real-time PCR","volume":"23","author":"Akta\u015f E","year":"2017","unstructured":"Akta\u015f E, Otlu B, Erdemir D, Ekici H, Bulut E. A first insight into Escherichia coli ST131 high-risk clone among extended-spectrum beta-lactamase-producing urine isolates in Istanbul with the use of matrix-assisted laser desorption\/ionization time-of-flight mass-spectrometry and real-time PCR. Microb Drug Resist 2017; 23(8): 1032\u20136. 10.1089\/mdr.2017.0021https:\/\/doi.org\/10.1089\/mdr.2017.0021"},{"key":"B23","series-title":"Yo\u011fun bak\u0131m ve poliklinik servislerinde yatan hastalardan izole edilen Escherichia coli izolatlar\u0131nda ST131 klonunun real-time PCR ile ara\u015ft\u0131r\u0131lmas\u0131","author":"Hasli F","year":"2019","unstructured":"Hasli F. Yo\u011fun bak\u0131m ve poliklinik servislerinde yatan hastalardan izole edilen Escherichia coli izolatlar\u0131nda ST131 klonunun real-time PCR ile ara\u015ft\u0131r\u0131lmas\u0131, MS thesis. Ondokuz May\u0131s Un\u0131vers\u0131ty; 2019."},{"key":"B24","article-title":"The European Committee on Antimicrobial Susceptibility testing. Breakpoint tables for interpretation of MICs and zone diameters","year":"2015","unstructured":"The European Committee on Antimicrobial Susceptibility testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, (2015) http:\/\/www.eucast.org, Accessed: 06.10.2022"},{"key":"B25","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement","first-page":"M100","author":"Clinical and Laboratory Standards Institute","year":"2015","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement. Clinical and Laboratory Standards Institute; 2015. p.\u00a0M100\u2013S25."},{"issue":"8","key":"B26","series-title":"J Clin Pathol","first-page":"872","article-title":"New method for detecting slime production by coagulase negative staphylococci","volume":"42","author":"Freeman DJ","year":"1989","unstructured":"Freeman DJ, Falkiner FR, Keane CT. New method for detecting slime production by coagulase negative staphylococci. J Clin Pathol 1989; 42(8): 872\u20134."},{"key":"B27","series-title":"Mol Biol Rep","first-page":"5949","article-title":"Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains","volume":"50","author":"Celebi D","year":"2023","unstructured":"Celebi D, Ayd\u0131n E, Rakici E, Baser S, Celebi O, Taghizadehghalehjoughi A. Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains. Mol Biol Rep 2023; 50: 5949\u20135956."},{"key":"B28","series-title":"Egypt J Med Hum Genet","first-page":"269","article-title":"Biofilm formation and presence of icaAD gene in clinical isolates of staphylococci","volume":"13","author":"Nasr AR","year":"2012","unstructured":"Nasr AR, AbuShady MH, Hussein SH. Biofilm formation and presence of icaAD gene in clinical isolates of staphylococci. Egypt J Med Hum Genet 2012; 13: 269\u2013274."},{"key":"B29","series-title":"J Microbiol Methods","first-page":"175","article-title":"A\u00a0modified microtiter-plate test for quantification of staphylococcal biofilm formation","volume":"40","author":"Stepanovic S","year":"2000","unstructured":"Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. A\u00a0modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 2000; 40: 175\u2013179."},{"key":"B30","series-title":"Short protocols in molecular biology","author":"Ausubel FM","year":"1995","unstructured":"Ausubel FM, Brient R, Kingston RE, Moore DD, Seidman JG, Smith JA, et\u00a0al. Short protocols in molecular biology, 2nd ed. New York: John Willey & Sons; 1995."},{"key":"B31","series-title":"Appl Environ Microbiol","first-page":"4555","article-title":"Rapid and simple determination of the Escherichia coli phylogenetic group","volume":"66","author":"Clermont O","year":"2000","unstructured":"Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555\u20134558."},{"issue":"3","key":"B32","series-title":"Acta Veterinaria Hungarica","first-page":"223","article-title":"Determination and molecular analysis of antibiotic resistance in Gram-negative enteric bacteria isolated from Pelophylax sp. in the Eastern Black Sea region","volume":"69","author":"Rakici E","year":"2021","unstructured":"Rakici E, Altunisik A, Sahin K, Ozgumus OB. Determination and molecular analysis of antibiotic resistance in Gram-negative enteric bacteria isolated from Pelophylax sp. in the Eastern Black Sea region. Acta Veterinaria Hungarica 2021; 69(3): 223\u2013233."},{"key":"B33","series-title":"Int J Microbiol","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8840561","article-title":"Prevalence of E. coli ST131 among uropathogenic E. coli isolates from Iraqi patients in Wasit Province, Iraq","author":"Al-Guranie DR","year":"2020","unstructured":"Al-Guranie DR, Al-Mayahie SM. Prevalence of E. coli ST131 among uropathogenic E. coli isolates from Iraqi patients in Wasit Province, Iraq. Int J Microbiol 2020: 8840561. 10.1155\/2020\/8840561https:\/\/doi.org\/10.1155\/2020\/8840561"},{"issue":"11","key":"B34","series-title":"J Antimicrob Chemother","first-page":"2973","article-title":"Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe","volume":"73","author":"Merino I","year":"2018","unstructured":"Merino I, Hern\u00e1ndez-Garc\u00eda M, Turrientes MC, P\u00e9rez-Viso B, L\u00f3pez-Fresne\u00f1a N, Diaz-Agero C, et al. Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe. J Antimicrob Chemother 2018; 73(11): 2973\u20132980."},{"issue":"1","key":"B35","series-title":"J Antimicrob Chemother","first-page":"72","article-title":"Change in the prevalence of extended-spectrum-\u03b2-lactamase-producing Escherichia coli in Japan by clonal spread","volume":"63","author":"Suzuki S","year":"2008","unstructured":"Suzuki S, Shibata N, Yamane K, Wachino J-i, Ito K, Arakawa Y. Change in the prevalence of extended-spectrum-\u03b2-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 2008; 63(1): 72\u20139."},{"key":"B36","series-title":"J Infect","first-page":"146","article-title":"Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea","volume":"60","author":"Lee MY","year":"2010","unstructured":"Lee MY, Choi HJ, Choi JY, Song M, Song Y, Kim S, et al. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea. J Infect 2010; 60: 146\u2013153."},{"key":"B37","series-title":"Abstracts of the forty-ninth interscience conference on antimicrobial agents and chemotherapy","article-title":"Characteristics of infections caused by extended-spectrum b-lactamase (ESBL)-producing Escherichia coli from community hospitals in South Africa","author":"Peirano G","year":"2010","unstructured":"Peirano G, Van Greune C, Pitout J. Characteristics of infections caused by extended-spectrum b-lactamase (ESBL)-producing Escherichia coli from community hospitals in South Africa. In: Abstracts of the forty-ninth interscience conference on antimicrobial agents and chemotherapy. Boston, MA: American Society for Microbiology; 2010. Abstract C2-682. Washington, DC, USA."},{"key":"B38","series-title":"Front Microbiol","article-title":"Antimicrobial resistance profiling and molecular epidemiological analysis of extended spectrum \u03b2-lactamases produced by extraintestinal invasive Escherichia coli isolates from Ethiopia: the presence of international high-risk clones ST131 and ST410 revealed","volume":"12","author":"Negeri AA","year":"2021","unstructured":"Negeri AA, Mamo H, Gurung JM, Firoj Mahmud AKM, F\u00e4llman M, Seyoum ET, et\u00a0al. Antimicrobial resistance profiling and molecular epidemiological analysis of extended spectrum \u03b2-lactamases produced by extraintestinal invasive Escherichia coli isolates from Ethiopia: the presence of international high-risk clones ST131 and ST410 revealed. Front Microbiol 2021; 12: 706846."},{"issue":"20","key":"B39","series-title":"Int J Mol Sci","first-page":"5162","article-title":"Prevalence of quinolone resistance of extended-spectrum \u03b2-lactamase-producing Escherichia coli with ST131-fimH30 in a city hospital in Hyogo, Japan","volume":"20","author":"Teramae M","year":"2019","unstructured":"Teramae M, Osawa K, Shigemura K, Kitagawa K, Shirakawa T, Fujisawa M, et al. Prevalence of quinolone resistance of extended-spectrum \u03b2-lactamase-producing Escherichia coli with ST131-fimH30 in a city hospital in Hyogo, Japan. Int J Mol Sci 2019; 20(20): 5162."},{"issue":"9","key":"B40","series-title":"J Clin Microbiol","first-page":"2974","article-title":"Phylogenetic distribution of CTX-M- and non-extended-spectrum beta-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes","volume":"50","author":"Brisse S","year":"2012","unstructured":"Brisse S, Diancourt L, Laouenan C, Vigan M, Caro V, Arlet G, et\u00a0al. Phylogenetic distribution of CTX-M- and non-extended-spectrum beta-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J Clin Microbiol 2012; 50(9): 2974\u201381."},{"issue":"6","key":"B41","series-title":"Antimicrob Agents Chemother","first-page":"3424","article-title":"Clinical epidemiology and molecular analysis of extended-spectrum-beta-lactamase producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648","volume":"59","author":"Sherchan JB","year":"2015","unstructured":"Sherchan JB, Hayakawa K, Miyoshi-Akiyama T, Ohmagari N, Kirikae T, Nagamatsu M, et\u00a0al. Clinical epidemiology and molecular analysis of extended-spectrum-beta-lactamase producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648. Antimicrob Agents Chemother 2015; 59(6): 3424\u20133432."},{"key":"B42","article-title":"Determination of the 025b-st131 clone of Escherichia coli and CTX-M-15- like extended-spectrum beta lactamase by PCR","author":"G\u00fcller \u00d6","year":"2021","unstructured":"G\u00fcller \u00d6. Determination of the 025b-st131 clone of Escherichia coli and CTX-M-15- like extended-spectrum beta lactamase by PCR, 2021."},{"key":"B43","series-title":"The relationship of ST131\/H30 clone\/subclone with virulence in quinolone-resistant and sensitive invasive Escherichia coli blood isolates","author":"G\u00fcrp\u0131nar \u00d6","year":"2018","unstructured":"G\u00fcrp\u0131nar \u00d6. The relationship of ST131\/H30 clone\/subclone with virulence in quinolone-resistant and sensitive invasive Escherichia coli blood isolates Master Thesis. Hacettepe University; 2018."},{"issue":"1","key":"B44","series-title":"BMC Microbiol","article-title":"Clonal diversity, virulence genes content and subclone status of Escherichia coli sequence type 131: comparative analysis of E. coli ST131 and non-ST131 isolates from Iran","volume":"19","author":"Hojabri Z","year":"2019","unstructured":"Hojabri Z, Darabi N, Arab M, Saffari F, Pajand O. Clonal diversity, virulence genes content and subclone status of Escherichia coli sequence type 131: comparative analysis of E. coli ST131 and non-ST131 isolates from Iran. BMC Microbiol 2019; 19(1)."},{"issue":"1","key":"B45","series-title":"Int J Antimicrob Agents","first-page":"19","article-title":"Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals","volume":"36","author":"Peirano G","year":"2010","unstructured":"Peirano G, Costello M, Pitout JD. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Int J Antimicrob Agents 2010; 36(1): 19\u201323."},{"key":"B46","first-page":"1","article-title":"Determination of ST131 sequence type and subclones in Escherichia coli isolates, which are the causative agents of urinary tract infection","author":"Er DK","year":"2016","unstructured":"Er DK, D\u00fcndar D, Uzuner H. Determination of ST131 sequence type and subclones in Escherichia coli isolates, which are the causative agents of urinary tract infection. 2016; 1\u201337."},{"issue":"3","key":"B47","series-title":"Ann Lab Med","first-page":"271","article-title":"Prevalence of Escherichia coli carrying pks islands in bacteremia patients","volume":"38","author":"Lee E","year":"2018","unstructured":"Lee E, Lee Y. Prevalence of Escherichia coli carrying pks islands in bacteremia patients. Ann Lab Med 2018; 38(3): 271\u2013273."},{"issue":"11","key":"B48","series-title":"J Antimicrob Chemother","first-page":"2612","article-title":"Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-\u03b2-lactamase-producing Escherichia coli in Japan","volume":"67","author":"Matsumura Y","year":"2012","unstructured":"Matsumura Y, Yamamoto M, Nagao M, Hotta G, Matsushima A, Ito Y, et\u00a0al. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-\u03b2-lactamase-producing Escherichia coli in Japan. J Antimicrob Chemother 2012; 67(11): 2612\u20132620."},{"issue":"1","key":"B49","series-title":"J Antimicrob Chemother","first-page":"1","article-title":"Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain","volume":"66","author":"Rogers BA","year":"2011","unstructured":"Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011; 66(1): 1\u201314."},{"issue":"10","key":"B50","series-title":"Eur J Clin Microbiol Infect Dis","first-page":"1859","article-title":"Molecular epidemiology of Escherichia coli sequence type 131 and its H30\/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran","volume":"36","author":"Hojabri Z","year":"2017","unstructured":"Hojabri Z, Mirmohammadkhani M, Kamali F, Ghassemi K, Taghavipour S, Pajand O. Molecular epidemiology of Escherichia coli sequence type 131 and its H30\/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran. Eur J Clin Microbiol Infect Dis 2017; 36(10): 1859\u20131866."},{"issue":"1","key":"B51","series-title":"Saudi J Biol Sci","first-page":"296","article-title":"Prevalence and molecular characteristics of sequence type 131 clone among clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia","volume":"27","author":"Alqasim A","year":"2020","unstructured":"Alqasim A, Abu Jaffal A, Alyousef AA. Prevalence and molecular characteristics of sequence type 131 clone among clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia. Saudi J Biol Sci 2020; 27(1): 296\u2013302."},{"key":"B52","series-title":"Can J Infect Dis Med Microbiol","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3826186","article-title":"Characterization of integrons and antimicrobial resistance in Escherichia coli sequence type 131 isolates","volume":"2020","author":"Huang J","year":"2020","unstructured":"Huang J, Lan F, Lu Y, Li B. Characterization of integrons and antimicrobial resistance in Escherichia coli sequence type 131 isolates. Can J Infect Dis Med Microbiol 2020; 2020: 3826186. 10.1155\/2020\/3826186https:\/\/doi.org\/10.1155\/2020\/3826186"},{"issue":"12","key":"B53","series-title":"Microb Genom","article-title":"Genomic comparisons of Escherichia coli ST131 from Australia","volume":"7","author":"Li D","year":"2021","unstructured":"Li D, Wyrsch ER, Elankumaran P, Dolejska M, Marenda MS, Browning GF, et\u00a0al. Genomic comparisons of Escherichia coli ST131 from Australia. Microb Genom 2021; 7(12): 000721."},{"key":"B54","series-title":"J Antimicrob Chemother","first-page":"1024","article-title":"The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup","volume":"61","author":"Clermont O","year":"2008","unstructured":"Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, Branger C, et\u00a0al. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 2008; 61: 1024\u20131028."},{"issue":"10","key":"B55","series-title":"J Clin Microbiol","first-page":"3270","article-title":"Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women","volume":"51","author":"Kudinha T","year":"2013","unstructured":"Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL. Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women. J Clin Microbiol 2013; 51(10): 3270\u20133276."},{"issue":"14","key":"B56","series-title":"Infect Drug Resist","first-page":"2625","article-title":"Epidemic potential of Escherichia coli O16:H41-ST131: compared with pandemic O25b:H30-ST131 lineage","volume":"8","author":"Zhang S","year":"2021","unstructured":"Zhang S, Zhang Q, Huang J, Cao Y, Zhao Z, Li B. Epidemic potential of Escherichia coli O16:H41-ST131: compared with pandemic O25b:H30-ST131 lineage. Infect Drug Resist 2021; 8(14): 2625\u20132632."}],"container-title":["Acta Microbiologica et Immunologica Hungarica"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/72\/3\/article-p226.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/030\/72\/3\/article-p226.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/030\/72\/3\/article-p226.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:47:11Z","timestamp":1759996031000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/72\/3\/article-p226.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":56,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1556\/030.2025.02710","relation":{},"ISSN":["1217-8950","1588-2640"],"issn-type":[{"value":"1217-8950","type":"print"},{"value":"1588-2640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}